Company Name: Selecta Biosciences, Inc.

Selecta Biosciences, Inc. is a clinical stage biopharmaceutical company. The company is engaged in the development of targeted therapies designed to modulate the immune system using its proprietary synthetic vaccine particle (SVP) technology.   

Ticker Symbol: SELB (NASDAQ)

Company Website: http://selectabio.com

Social Media: Selecta Biosciences LinkedIn

Headquarters: Watertown, MA